These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 8596038)

  • 1. Receptors on T cells escaping superantigen-mediated deletion lack special beta-chain junctional region structural characteristics.
    Pullen AM; Bogatzki LY
    J Immunol; 1996 Mar; 156(5):1865-72. PubMed ID: 8596038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of key amino acids of the mouse mammary tumor virus superantigen involved in the specific interaction with T-cell receptor V(beta) domains.
    Baribaud F; Wirth S; Maillard I; Valsesia S; Acha-Orbea H; Diggelmann H
    J Virol; 2001 Aug; 75(16):7453-61. PubMed ID: 11462017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T cell receptor V beta repertoire in mice lacking endogenous mouse mammary tumor provirus.
    Braun MY; Jouvin-Marche E; Marche PN; MacDonald HR; Acha-Orbea H
    Eur J Immunol; 1995 Mar; 25(3):857-62. PubMed ID: 7705418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Persistence of V beta 6+ T cells in Mls-1a mice. A role for the third complementarity-determining region (CDR3) of the T cell receptor beta chain in superantigen recognition.
    Chies JA; Marodon G; Joret AM; Regnault A; Lembezat MP; Rocha B; Freitas AA
    J Immunol; 1995 Nov; 155(9):4171-8. PubMed ID: 7594572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A V beta 8.2-specific superantigen from exogenous mouse mammary tumor virus carried by FM mice.
    Yoshimoto T; Nagase H; Nakano H; Matsuzawa A; Nariuchi H
    Eur J Immunol; 1994 Jul; 24(7):1612-9. PubMed ID: 7913038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of two structurally identical viral superantigens results in thymic elimination at distinct developmental stages.
    Morishima C; Norby-Slycord C; McConnell KR; Finch RJ; Nelson AJ; Farr AG; Pullen AM
    J Immunol; 1994 Dec; 153(11):5091-103. PubMed ID: 7963568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MHC-specific recognition of a bacterial superantigen by weakly reactive T cells.
    Surman S; Deckhut AM; Blackman MA; Woodland DL
    J Immunol; 1994 May; 152(10):4893-902. PubMed ID: 8176210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maternal transfer of infectious mouse mammary tumor retroviruses does not depend on clonal deletion of superantigen-reactive V beta 14+ T cells.
    Penninger JM; Wallace VA; Timms E; Mak TW
    Eur J Immunol; 1994 May; 24(5):1102-8. PubMed ID: 8181521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of MMTV superantigen presentation in MHC class II-deficient mice.
    Beutner U; McLellan B; Kraus E; Huber BT
    Cell Immunol; 1996 Mar; 168(2):141-7. PubMed ID: 8640859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A V beta 4-specific superantigen encoded by a new exogenous mouse mammary tumor virus.
    Maillard I; Erny K; Acha-Orbea H; Diggelmann H
    Eur J Immunol; 1996 May; 26(5):1000-6. PubMed ID: 8647159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concomitant infection with exogenous mouse mammary tumor virus encoding I-E-dependent superantigen in I-E-negative mouse strain.
    Ando Y; Wajjwalku W; Niimi N; Hiromatsu K; Morishima T; Yoshikai Y
    J Immunol; 1995 Jun; 154(12):6219-26. PubMed ID: 7759859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of superantigen recognition by peptides of the variable region of the T cell receptor beta chain.
    MacNeil D; Fraga E; Singh B
    Eur J Immunol; 1992 Apr; 22(4):937-41. PubMed ID: 1532364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of a V beta 2-specific superantigen with a tumorigenic milk-borne mouse mammary tumor virus.
    Hodes RJ; Novick MB; Palmer LD; Knepper JE
    J Immunol; 1993 Feb; 150(4):1422-8. PubMed ID: 8094408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional and phenotypic change of T cells in murine acquired immune deficiency.
    Kanagawa O; Gayama S; Vaupel B
    J Immunol; 1994 May; 152(9):4671-9. PubMed ID: 8157980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of the Mlsf system. II. Identification of mouse mammary tumor virus proviruses involved in the clonal deletion of self-Mlsf-reactive T cells.
    Foo-Phillips M; Kozak CA; Principato MA; Abe R
    J Immunol; 1992 Dec; 149(11):3440-7. PubMed ID: 1331236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selection for amino acid sequence and J beta element usage in the beta chain of DBA/2V beta b- and DBA/2V beta a-derived myoglobin-specific T cell clones.
    Ruberti G; Paragas V; Kim D; Fathman CG
    J Immunol; 1993 Dec; 151(11):6185-94. PubMed ID: 8245460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences in the avidity of TCR interactions with a superantigenic ligand affect negative selection but do not allow positive selection.
    Chervonsky AV; Golovkina TV; Ross SR; Janeway CA
    J Immunol; 1995 Dec; 155(11):5115-23. PubMed ID: 7594520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression and presentation of endogenous mouse mammary tumor virus superantigens by thymic and splenic dendritic cells and B cells.
    Ardavín C; Waanders G; Ferrero I; Anjuère F; Acha-Orbea H; MacDonald HR
    J Immunol; 1996 Oct; 157(7):2789-94. PubMed ID: 8816381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Junctional diversity prevents negative selection of an antigen-specific T cell repertoire.
    Kilgannon P; Novak Z; Fotedar A; Singh B
    Mol Immunol; 2010 Feb; 47(5):1154-60. PubMed ID: 19954850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The J alpha segment contributes to the affinity of V beta 6+ cells for vSAG-7 (Mls-1a) presented by I-A molecules.
    Churaqui E; Oukka M; Tilloy F; Mayadoux E; Bruley-Rosset M; Kosmatopoulos K
    Immunology; 1995 Apr; 84(4):609-18. PubMed ID: 7790035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.